The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 756K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

11 articles for X Xia


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Novel ferulic amide derivatives with tertiary amine side chain as acetylcholinesterase and butyrylcholinesterase inhibitors: The influence of carbon spacer length, alkylamine and aromatic group.EBI
Hu'Nan University
Polyketides witha-Glucosidase Inhibitory Activity from a Mangrove Endophytic Fungus, Penicillium sp. HN29-3B1.EBI
Hebei University
Fragment based drug discovery: practical implementation based on¹¿F NMR spectroscopy.EBI
Amgen
Discovery and optimization of a novel series of N-arylamide oxadiazoles as potent, highly selective and orally bioavailable cannabinoid receptor 2 (CB2) agonists.EBI
Amgen
Development of Antibacterial Peptides with Membrane Disruption and Folate Pathway Inhibitory Activities against Methicillin-Resistant Staphylococcus aureus.EBI
Qilu University of Technology (Shandong Academy of Sciences)
Design, Synthesis, and Pharmacological Evaluation of Multisubstituted Pyrido[4,3-EBI
Shanghai Jiao Tong University
Pioneering 4,11-Dioxo-4,11-dihydro-1EBI
Shanghai Jiao Tong University
Novel Reversible-Binding PET Ligands for Imaging Monoacylglycerol Lipase Based on the Piperazinyl Azetidine Scaffold.EBI
Massachusetts General Hospital
Allosteric EGFR inhibitors and methods of use thereofBDB
Dana-Farber Cancer Institute
P38 MAP kinase inhibitorsBDB
Respivert
Thieno[3,2-C]pyridine kinase inhibitors with improved CYP safety profileBDB
Abbvie